Background. The renin-angiotensin system with its renal-humoral and local myocardial components plays an important role in the development and progression of chronic heart failure. Whereas angiotensin receptors have been found in atrial and ventricular myocardium of different species including humans, its influence on myocardial contractility is not yet defined in human failing myocardium and especially in human nonfailing myocardium.
tractility,21'22 because no inotropic effect of angiotensin II was found in guinea pig myocardium13; negative inotropic effects of angiotensin II were observed in cultured neonatal rat cardiomycytes23 and different results were obtained in dog myocardium. 24 Furthermore, only one study is available that deals with the inotropic effect of angiotensin in human preparations. 25 Additionally, at present no data are available that are obtained from normal or nonfailing left ventricular human myocardium.
The question of whether human failing and nonfailing myocardia of atria and ventricles responds to angiotensin with an increase in contractility may be of some clinical importance: Angiotensin converting enzyme inhibition might prevent or abolish positive inotropism of the angiotensin II. Therefore, we investigated the effects of angiotensin I and II in human myocardium obtained from right atria and from failing and nonfailing left ventricles of adult patients. Because of the higher number of angiotensin II receptors in myocardium from young individuals,2 right ventricular preparations from infants with tetralogy of Fallot were also studied. Because positive inotropic effects are temperature and heart rate dependent,18 all experiments were conducted at physiological conditions (37°C experimental temperature; 60 beats per minute stimulation rate).
The findings were unexpected in as far as atrial preparations showed constant effects of angiotensin on isometric force development, whereas a positive inotropic response was not observed in the preparations from failing and nonfailing left ventricles. The results are of clinical relevance because they support the view that angiotensin converting enzyme inhibition reduces force development of the atria and thereby filling pressure of the ventricles in chronic heart failure but leaves contractility of the left ventricle unaltered.
Methods

Human Cardiac Tissues
Myocardium from human hearts used in the present study was obtained from four different sources. First, small pieces of the right atrium were received from 44 patients (38 men, 6 women; 40 to 78 years old) undergoing routine aortocoronary bypass surgery because of two-or three-vessel disease without manifestation of congestive heart failure. Mean left ventricular ejection fraction was 57±4.0%, and all patients were in sinus rhythm. During transportation, the cardiac tissue was stored in Krebs-Ringer solution that contained 30 mmol/L 2,3-butanedione monoxime (BDM, see below) at room temperature. The solution was constantly bubbled with a gas mixture of 95% 02 and 5% CO2. The maximum time that passed between excision of the tissue and the end of preparation was 30 minutes. From each specimen up to four myocardial strips were prepared. Second, parts of the left ventricular papillary muscle were taken from patients undergoing routine mitral valve replacement because of mitral valve stenosis or mitral valve regurgitation. Four of these patients had mitral valve stenosis (two men, two women) and two had mitral valve regurgitation (one woman, one man). The time for transportation and preparation was 30 minutes. These six patients had a mean age of 63 years, and their left ventricular ejection fraction was 53+±7%. Third, myocardium from the left ventricle was obtained from 9 explanted hearts of patients with dilated cardiomyopathy being in endstage heart failure. The mean age was 57, and all of the patients were in New York Heart Association class III or IV. Left ventricular ejection fraction was 16±1%. All of the patients were treated with digitalis (digoxin or digitoxin) and angiotensin converting enzyme inhibitors (captopril, enalapril). Three patients had intravenous low-dose dopamine. Also, one normal donor heart was received that could not be used for transplantation for technical reasons. After explantation, papillary muscle and parts of the left ventricular wall were dissected and immediately submerged into Krebs-Ringer solution at room temperature containing 30 mmol/L BDM. Transportation plus preparation time was 30 minutes in four preparations, 1 hour in two preparations, and 4 hours for all other cases. Fourth, small pieces of the right ventricle of four infants were received. The age of the children was between 8 and 42 months: these children underwent reconstructive heart surgery for tetralogy of Fallot. Right ventricular muscle tissue was immediately submerged into room-temperature, BDM-containing Krebs-Ringer solution, which was bubbled with a 95% 02 and 5% Co2 gas mixture. The time of the myocardium being in BDM-containing solution was 2 hours and 30 minutes for all cases.
To exclude the possibility that the time during which the myocardium was kept in BDM-containing solution had any significant influence on the functional integrity of angiotensin II receptors and on the viability of these preparations, additional animal studies were performed. Because the hamster myocardium is especially sensitive to angiotensin II, this species was chosen. Ten Syrian hamsters (strain Han: AURA) weighing between 100 and 140 g were anesthetized and killed. In six preparations, experiments were performed immediately after cardiotomy so that the time in BDM-containing solution was less than 30 minutes. In the other eight preparations, experiments were carried out after an exposure to BDM-containing solution for a period of 6 hours. In the first group, peak developed isometric tension was 7.1±0.9 mN/mm2 and in the second group, 6.9±0.7 mN/mm2 (NS). These preparations were exposed to increasing concentrations of angiotensin II (Fig 1) . Between the two groups, no significant differences could be found regarding the dose-response curves. At 10-6 mol/L angiotensin II, isometric tension increased to 226±19% in the first group (30 minutes in BDM) and to 204±7% in the second group (6 hours in BDM). The responsiveness of hamster myocardium to angiotensin II was not significantly different between the two groups. From these data, two conclusions can be drawn: First, the function of the angiotensin II receptors appear to be independent on BDM pretreatment and on the time of the treatment. Second, the data demonstrated unchanged viability of these preparations that were exposed to BDM over a period of 6 hours.
Solutions, Instruments, and Study Protocol
The solution used in this study contained (mmol/L): In 50% of all experiments, the quality of the preparation was tested at the end of the experimental protocol according to Paradise et al. 28 Developed tension never decreased more than 10% in any of the preparations when the Krebs-Ringer solution was bubbled with 15% N2/5% C02/80% 02. This suggests that no hypoxia was present in the preparations under the experimental conditions used.
Microscopic Investigations
When experiments were performed in preparations after mechanical removal of the endocardium, routine histological investigations were performed at the end of the protocol. In all preparations, complete removal of the endocardium was shown. 17 .2±4.7 mN/mm2 (P<.01, Fig 4) . To study the specifity of angiotensin II effect, preparations were pretreated with 10-5 mol/L saralasin before addition of angiotensin II. Under these conditions, the angiotensin II effect was completely eliminated (Fig 4) . 
Materials and Concentrations
Myocardial Preparations From Left Ventricles
Altogether, 32 left ventricular myocardial preparations obtained from 16 individuals were studied. On the average, muscle cross-sectional area, muscle length, and peak twitch tension were 0.63+0.11 mm2, 4.6±0.2 mm, and 7.5 ±0.9 mN/mm2, respectively. Neither angiotensin I nor angiotensin II showed significant effects in any of the preparations (Tables 2 and 3 (Table 4) .
Discussion
Background of the Study Three important mechanisms are well known to regulate myocardial contractility: (1) According to Starling,31 preload defines maximum developed force. (2) Force development depends on heart rate32: In the nonfailing human myocardium, force development increases with higher heart rates.33-35 These two mechanisms are inherent to the myocardium and present a kind of autoregulation of the heart as a pump. (3) In addition, the sympathetic nervous system modulates myocardial contractility via release of catecholamines, which activate 131-and P32-adrenoceptors.36 The latter system displays a feedback control system between peripheral circulation and the pump and couples myocardial function to the central nervous system.
Under certain circumstances, a fourth system may come into play and interact with the mentioned mechanisms, the renin-angiotensin system. The renin-angiotensin system is activated under pathological conditions, ie, loss of salt and water and in bleeding and cardiogenic shock, and plays a fundamental role in the development and progression of chronic heart failure.3.37.38 Although the importance of the renin-angiotensin system in heart failure patients is now very well recognized and the benefit of angiotensin converting enzyme inhibitors has been shown and led to a worldwide use of these compounds, the effect of angiotensin on myocardial function is still discussed controversially. The positive inotropic effect of angiotensin II seems to be differently pronounced between species. Koch-Weser was the first to demonstrate clear positive inotropic effects in ventricular myocardium.17,18 In contrast, angiotensin exerted only small effects in atrial preparations of cats. Furthermore, the quantity of the positive inotropic effect was shown to depend on physical factors, ie, heart rate, experimental temperature, and calcium concentration. 18 
Nature of the Positive Inotropic Effects ofAngiotensin I and II
To obtain more information about the molecular mechanisms of the positive inotropic effects of angiotensin I and II in atrial preparations, more experiments were performed. Inotropic effects of angiotensin may be mediated by facilitation of the release of endogenous catecholamines from their intramyocardial stores. 42, 43 To rule out such a mechanism, preparations were pretreated by the a-blocker prazosin and the pl-blocker propranolol. Neither pretreatment prevented the inotropic responses of atrial preparations to angiotenin I and II, either qualitatively or quantitatively (Fig 4) . Therefore, the inotropic effect of angiotensin I and II appears to be directly mediated by angiotensin II receptors. This is shown by application of saralasin, which completely inhibited the inotropic effects of angiotensin I and II at all concentrations studied (Figs 4 and 5) . On the other hand, pretreatment with enalaprilate prevents only the inotropic effect of angiotensin I. This finding indicates that an angiotensin converting enzyme exists in the myocardial preparation that is necessary for the inotropic action of angiotensin I. Furthermore, mechanical skinning of the endocardium had no influence on the inotropic response to angiotensin I, which indicates that the angiotensin converting enzyme is not exclusively localized in the endocardium but rather presents one enzyme of a complete renin-angiotensin system being regionally present in the myocardium per se. 
